Cargando…

Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer

BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guo, Chen, Xiong, Quan, Zhen, Liu, Miao, Guo, Yuan, Tang, Yangbin, Peng, Lang, Wang, Leilei, Wu, Yingying, Wu, Xiaohou, Liu, Jiayu, Zheng, Yongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043306/
https://www.ncbi.nlm.nih.gov/pubmed/36998469
http://dx.doi.org/10.3389/fonc.2023.1048521
_version_ 1784913116384985088
author Yang, Guo
Chen, Xiong
Quan, Zhen
Liu, Miao
Guo, Yuan
Tang, Yangbin
Peng, Lang
Wang, Leilei
Wu, Yingying
Wu, Xiaohou
Liu, Jiayu
Zheng, Yongbo
author_facet Yang, Guo
Chen, Xiong
Quan, Zhen
Liu, Miao
Guo, Yuan
Tang, Yangbin
Peng, Lang
Wang, Leilei
Wu, Yingying
Wu, Xiaohou
Liu, Jiayu
Zheng, Yongbo
author_sort Yang, Guo
collection PubMed
description BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa remain unclear. Our study aimed to investigate the forkhead box A1 (FOXA1)-related ceRNA regulatory network and ascertain potential prognostic markers associated with PCa. METHODS: RNA sequence profiles downloaded from The Cancer Genome Atlas (TCGA) were analyzed to recognize differentially expressed genes (DEGs) derived from tumor and non-tumor adjacent samples as well as FOXA1(low) and FOXA1(high) tumor samples. The enrichment analysis was conducted for the dysregulated mRNAs. The network for the differentially expressed long non-coding RNA (lncRNA)-associated ceRNAs was then established. Survival analysis and univariate Cox regression analysis were executed to determine independent prognostic RNAs associated with PCa. The correlation between DUSP2 and immune cell infiltration level was analyzed. Tissue and blood samples were collected to verify our network. Molecular experiments were performed to explore whether DUSP2 is involved in the development of PCa. RESULTS: A ceRNA network related to FOXA1 was constructed and comprised 18 lncRNAs, 5 miRNAs, and 44 mRNAs. The MAGI2-AS3~has-mir-106a/has-mir-204~DUSP2 ceRNA regulatory network relevant to the prognosis of PCa was obtained by analysis. We markedly distinguished the MAGI2-AS3/DUSP2 axis in the ceRNA. It will most likely become a clinical prognostic model and impact the changes in the tumor immune microenvironment of PCa. The abnormal MAGI2-AS3 expression level from the patients’ blood manifested that it would be a novel potential diagnostic biomarker for PCa. Moreover, down-expressed DUSP2 suppressed the proliferation and migration of PCa cells. CONCLUSIONS: Our findings provide pivotal clues to understanding the role of the FOXA1-concerned ceRNA network in PCa. Simultaneously, this MAGI2-AS3/DUSP2 axis might be a new significant prognostic factor associated with the diagnosis and prognosis of PCa.
format Online
Article
Text
id pubmed-10043306
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100433062023-03-29 Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer Yang, Guo Chen, Xiong Quan, Zhen Liu, Miao Guo, Yuan Tang, Yangbin Peng, Lang Wang, Leilei Wu, Yingying Wu, Xiaohou Liu, Jiayu Zheng, Yongbo Front Oncol Oncology BACKGROUND: Prostate cancer (PCa) is the second most common cause of cancer-related deaths in American men. Even though increasing evidence has disclosed the competitive endogenous RNA (ceRNA) regulatory networks among cancers, the complexity and behavior characteristics of the ceRNA network in PCa remain unclear. Our study aimed to investigate the forkhead box A1 (FOXA1)-related ceRNA regulatory network and ascertain potential prognostic markers associated with PCa. METHODS: RNA sequence profiles downloaded from The Cancer Genome Atlas (TCGA) were analyzed to recognize differentially expressed genes (DEGs) derived from tumor and non-tumor adjacent samples as well as FOXA1(low) and FOXA1(high) tumor samples. The enrichment analysis was conducted for the dysregulated mRNAs. The network for the differentially expressed long non-coding RNA (lncRNA)-associated ceRNAs was then established. Survival analysis and univariate Cox regression analysis were executed to determine independent prognostic RNAs associated with PCa. The correlation between DUSP2 and immune cell infiltration level was analyzed. Tissue and blood samples were collected to verify our network. Molecular experiments were performed to explore whether DUSP2 is involved in the development of PCa. RESULTS: A ceRNA network related to FOXA1 was constructed and comprised 18 lncRNAs, 5 miRNAs, and 44 mRNAs. The MAGI2-AS3~has-mir-106a/has-mir-204~DUSP2 ceRNA regulatory network relevant to the prognosis of PCa was obtained by analysis. We markedly distinguished the MAGI2-AS3/DUSP2 axis in the ceRNA. It will most likely become a clinical prognostic model and impact the changes in the tumor immune microenvironment of PCa. The abnormal MAGI2-AS3 expression level from the patients’ blood manifested that it would be a novel potential diagnostic biomarker for PCa. Moreover, down-expressed DUSP2 suppressed the proliferation and migration of PCa cells. CONCLUSIONS: Our findings provide pivotal clues to understanding the role of the FOXA1-concerned ceRNA network in PCa. Simultaneously, this MAGI2-AS3/DUSP2 axis might be a new significant prognostic factor associated with the diagnosis and prognosis of PCa. Frontiers Media S.A. 2023-03-14 /pmc/articles/PMC10043306/ /pubmed/36998469 http://dx.doi.org/10.3389/fonc.2023.1048521 Text en Copyright © 2023 Yang, Chen, Quan, Liu, Guo, Tang, Peng, Wang, Wu, Wu, Liu and Zheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Guo
Chen, Xiong
Quan, Zhen
Liu, Miao
Guo, Yuan
Tang, Yangbin
Peng, Lang
Wang, Leilei
Wu, Yingying
Wu, Xiaohou
Liu, Jiayu
Zheng, Yongbo
Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title_full Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title_fullStr Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title_full_unstemmed Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title_short Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer
title_sort comprehensive analysis of the foxa1-related cerna network and identification of the magi2-as3/dusp2 axis as a prognostic biomarker in prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043306/
https://www.ncbi.nlm.nih.gov/pubmed/36998469
http://dx.doi.org/10.3389/fonc.2023.1048521
work_keys_str_mv AT yangguo comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT chenxiong comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT quanzhen comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT liumiao comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT guoyuan comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT tangyangbin comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT penglang comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT wangleilei comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT wuyingying comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT wuxiaohou comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT liujiayu comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer
AT zhengyongbo comprehensiveanalysisofthefoxa1relatedcernanetworkandidentificationofthemagi2as3dusp2axisasaprognosticbiomarkerinprostatecancer